ASND SCHEDULE 13G/A: SEC filing
T. Rowe Price Investment Management, Inc.
Filed with the SEC on · accession 0001897612-26-000734
ASND filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. T. Rowe Price Investment Management, Inc. filed an amended Schedule 13G reporting beneficial ownership of 8,194,812 ADRs of Ascendis Pharma A/S, representing 12.4% of the class, as of September 30, 2026. The stock moved -1.3% by the first close after the filing.
Summary of the filing
T. Rowe Price Investment Management, Inc. filed an amended Schedule 13G reporting beneficial ownership of 8,194,812 ADRs of Ascendis Pharma A/S, representing 12.4% of the class, as of September 30, 2026. The filing is a passive investment disclosure under Rule 13d-1(b).
Key details
How ASND stock reacted
Close before
$275.39
Nov 13, 2026
First close after
-1.33%
$271.73
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for ASND, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ASND?
Click hereFrequently asked questions
What did ASND file with the SEC on Nov 16, 2026?
ASND filed a SCHEDULE 13G/A (SEC filing). T. Rowe Price Investment Management, Inc. filed an amended Schedule 13G reporting beneficial ownership of 8,194,812 ADRs of Ascendis Pharma A/S, representing 12.4% of the class, as of September 30, 2026. The filing is a passive investment disclosure under Rule 13d-1(b).
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did ASND stock react to this filing?
ASND closed at $275.39 before the filing and $271.73 on Nov 16, 2026 (-1.33%).
Other ASND SEC filings
- 6-K · SEC filingNov 12, 2026
- 6-K · SEC filingNov 12, 2026
- 6-K · SEC filingNov 12, 2026
- 6-K · Fda approvalNov 6, 2026
- SCHEDULE 13G/A · SEC filingNov 5, 2026
- 6-K · Fda approvalOct 26, 2026
- 6-K · Fda approvalOct 16, 2026
- 6-K · SEC filingOct 14, 2026
- 6-K · SEC filingSep 29, 2026
- 6-K · Contract terminationSep 15, 2026
Get alerts when ASND files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days